nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Fluocinonide—SMO—bone cancer	0.0854	0.396	CrCbGaD
Desonide—Telangiectasia—Methotrexate—bone cancer	0.047	0.0599	CcSEcCtD
Desonide—Secondary infection—Epirubicin—bone cancer	0.0352	0.0449	CcSEcCtD
Desonide—Secondary infection—Doxorubicin—bone cancer	0.0326	0.0416	CcSEcCtD
Desonide—Leukoderma—Methotrexate—bone cancer	0.026	0.0332	CcSEcCtD
Desonide—Infection—Carboplatin—bone cancer	0.0244	0.0311	CcSEcCtD
Desonide—Leukoderma—Epirubicin—bone cancer	0.0244	0.0311	CcSEcCtD
Desonide—Leukoderma—Doxorubicin—bone cancer	0.0225	0.0287	CcSEcCtD
Desonide—Pain—Carboplatin—bone cancer	0.021	0.0267	CcSEcCtD
Desonide—Skin exfoliation—Cisplatin—bone cancer	0.0193	0.0245	CcSEcCtD
Desonide—Folliculitis—Methotrexate—bone cancer	0.0176	0.0224	CcSEcCtD
Desonide—Folliculitis—Epirubicin—bone cancer	0.0165	0.021	CcSEcCtD
Desonide—Folliculitis—Doxorubicin—bone cancer	0.0152	0.0194	CcSEcCtD
Desonide—Irritability—Cisplatin—bone cancer	0.014	0.0178	CcSEcCtD
Desonide—Rash pustular—Epirubicin—bone cancer	0.013	0.0166	CcSEcCtD
Desonide—Stinging—Epirubicin—bone cancer	0.0128	0.0163	CcSEcCtD
Desonide—Hydrocortamate—CYP3A4—bone cancer	0.0121	0.0561	CrCbGaD
Desonide—Rash pustular—Doxorubicin—bone cancer	0.012	0.0153	CcSEcCtD
Desonide—Stinging—Doxorubicin—bone cancer	0.0118	0.0151	CcSEcCtD
Desonide—Viral infection—Epirubicin—bone cancer	0.0115	0.0146	CcSEcCtD
Desonide—Budesonide—CYP3A4—bone cancer	0.0112	0.0521	CrCbGaD
Desonide—Viral infection—Doxorubicin—bone cancer	0.0106	0.0135	CcSEcCtD
Desonide—Skin exfoliation—Methotrexate—bone cancer	0.0106	0.0135	CcSEcCtD
Desonide—Dermatitis contact—Epirubicin—bone cancer	0.0102	0.013	CcSEcCtD
Desonide—Skin exfoliation—Epirubicin—bone cancer	0.00989	0.0126	CcSEcCtD
Desonide—Alclometasone—CYP3A4—bone cancer	0.00969	0.0449	CrCbGaD
Desonide—Dermatitis contact—Doxorubicin—bone cancer	0.00947	0.0121	CcSEcCtD
Desonide—Flunisolide—CYP3A4—bone cancer	0.00943	0.0438	CrCbGaD
Desonide—Paramethasone—CYP3A4—bone cancer	0.00931	0.0432	CrCbGaD
Desonide—Ciclesonide—CYP3A4—bone cancer	0.00916	0.0425	CrCbGaD
Desonide—Skin exfoliation—Doxorubicin—bone cancer	0.00915	0.0117	CcSEcCtD
Desonide—Mediastinal disorder—Cisplatin—bone cancer	0.00913	0.0116	CcSEcCtD
Desonide—Fluorometholone—CYP3A4—bone cancer	0.00909	0.0422	CrCbGaD
Desonide—Erythema—Cisplatin—bone cancer	0.00882	0.0112	CcSEcCtD
Desonide—Methylprednisolone—CYP3A4—bone cancer	0.00879	0.0408	CrCbGaD
Desonide—Irritability—Methotrexate—bone cancer	0.00767	0.00977	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00745	0.0095	CcSEcCtD
Desonide—Triamcinolone—CYP3A4—bone cancer	0.00741	0.0344	CrCbGaD
Desonide—Triamcinolone—PTGS2—bone cancer	0.00725	0.0337	CrCbGaD
Desonide—Infection—Cisplatin—bone cancer	0.00715	0.00911	CcSEcCtD
Desonide—Nervous system disorder—Cisplatin—bone cancer	0.00706	0.00899	CcSEcCtD
Desonide—Skin disorder—Cisplatin—bone cancer	0.00699	0.00891	CcSEcCtD
Desonide—Hyperhidrosis—Cisplatin—bone cancer	0.00696	0.00887	CcSEcCtD
Desonide—Asthma—Methotrexate—bone cancer	0.00694	0.00885	CcSEcCtD
Desonide—Prednisone—CYP3A4—bone cancer	0.00672	0.0312	CrCbGaD
Desonide—Asthma—Epirubicin—bone cancer	0.0065	0.00828	CcSEcCtD
Desonide—Upper respiratory tract infection—Methotrexate—bone cancer	0.00645	0.00823	CcSEcCtD
Desonide—Prednisolone—CYP3A4—bone cancer	0.00619	0.0287	CrCbGaD
Desonide—Infestation NOS—Methotrexate—bone cancer	0.00619	0.00789	CcSEcCtD
Desonide—Infestation—Methotrexate—bone cancer	0.00619	0.00789	CcSEcCtD
Desonide—Pain—Cisplatin—bone cancer	0.00615	0.00784	CcSEcCtD
Desonide—Betamethasone—CYP3A4—bone cancer	0.00607	0.0282	CrCbGaD
Desonide—Upper respiratory tract infection—Epirubicin—bone cancer	0.00604	0.0077	CcSEcCtD
Desonide—Asthma—Doxorubicin—bone cancer	0.00601	0.00766	CcSEcCtD
Desonide—Betamethasone—PTGS2—bone cancer	0.00594	0.0276	CrCbGaD
Desonide—Sweating—Methotrexate—bone cancer	0.00593	0.00757	CcSEcCtD
Desonide—Hyperglycaemia—Epirubicin—bone cancer	0.00586	0.00747	CcSEcCtD
Desonide—Infestation—Epirubicin—bone cancer	0.00579	0.00738	CcSEcCtD
Desonide—Infestation NOS—Epirubicin—bone cancer	0.00579	0.00738	CcSEcCtD
Desonide—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00559	0.00712	CcSEcCtD
Desonide—Sweating—Epirubicin—bone cancer	0.00555	0.00708	CcSEcCtD
Desonide—Pharyngitis—Methotrexate—bone cancer	0.00552	0.00703	CcSEcCtD
Desonide—Hyperglycaemia—Doxorubicin—bone cancer	0.00542	0.00691	CcSEcCtD
Desonide—Infestation—Doxorubicin—bone cancer	0.00536	0.00683	CcSEcCtD
Desonide—Infestation NOS—Doxorubicin—bone cancer	0.00536	0.00683	CcSEcCtD
Desonide—Pharyngitis—Epirubicin—bone cancer	0.00516	0.00658	CcSEcCtD
Desonide—Sweating—Doxorubicin—bone cancer	0.00514	0.00655	CcSEcCtD
Desonide—Oedema peripheral—Epirubicin—bone cancer	0.00512	0.00653	CcSEcCtD
Desonide—Mediastinal disorder—Methotrexate—bone cancer	0.00501	0.00638	CcSEcCtD
Desonide—Mental disorder—Methotrexate—bone cancer	0.00487	0.00621	CcSEcCtD
Desonide—Erythema—Methotrexate—bone cancer	0.00484	0.00617	CcSEcCtD
Desonide—Pharyngitis—Doxorubicin—bone cancer	0.00478	0.00609	CcSEcCtD
Desonide—Oedema peripheral—Doxorubicin—bone cancer	0.00474	0.00604	CcSEcCtD
Desonide—Hydrocortisone—CYP3A4—bone cancer	0.00474	0.022	CrCbGaD
Desonide—Mediastinal disorder—Epirubicin—bone cancer	0.00469	0.00597	CcSEcCtD
Desonide—Mental disorder—Epirubicin—bone cancer	0.00456	0.00581	CcSEcCtD
Desonide—Rash—Cisplatin—bone cancer	0.00454	0.00578	CcSEcCtD
Desonide—Dermatitis—Cisplatin—bone cancer	0.00453	0.00578	CcSEcCtD
Desonide—Erythema—Epirubicin—bone cancer	0.00453	0.00577	CcSEcCtD
Desonide—Mediastinal disorder—Doxorubicin—bone cancer	0.00434	0.00553	CcSEcCtD
Desonide—Cough—Methotrexate—bone cancer	0.00422	0.00538	CcSEcCtD
Desonide—Mental disorder—Doxorubicin—bone cancer	0.00422	0.00537	CcSEcCtD
Desonide—Erythema—Doxorubicin—bone cancer	0.00419	0.00534	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00409	0.00521	CcSEcCtD
Desonide—Cough—Epirubicin—bone cancer	0.00395	0.00504	CcSEcCtD
Desonide—Infection—Methotrexate—bone cancer	0.00392	0.005	CcSEcCtD
Desonide—Nervous system disorder—Methotrexate—bone cancer	0.00387	0.00494	CcSEcCtD
Desonide—Skin disorder—Methotrexate—bone cancer	0.00383	0.00489	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00383	0.00488	CcSEcCtD
Desonide—Hyperhidrosis—Methotrexate—bone cancer	0.00382	0.00487	CcSEcCtD
Desonide—Infection—Epirubicin—bone cancer	0.00367	0.00468	CcSEcCtD
Desonide—Cough—Doxorubicin—bone cancer	0.00366	0.00466	CcSEcCtD
Desonide—Nervous system disorder—Epirubicin—bone cancer	0.00362	0.00462	CcSEcCtD
Desonide—Skin disorder—Epirubicin—bone cancer	0.00359	0.00457	CcSEcCtD
Desonide—Hyperhidrosis—Epirubicin—bone cancer	0.00357	0.00455	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00354	0.00451	CcSEcCtD
Desonide—Dexamethasone—CYP3A4—bone cancer	0.00353	0.0164	CrCbGaD
Desonide—Dexamethasone—PTGS2—bone cancer	0.00346	0.016	CrCbGaD
Desonide—Infection—Doxorubicin—bone cancer	0.0034	0.00433	CcSEcCtD
Desonide—Pain—Methotrexate—bone cancer	0.00338	0.0043	CcSEcCtD
Desonide—Nervous system disorder—Doxorubicin—bone cancer	0.00335	0.00427	CcSEcCtD
Desonide—Skin disorder—Doxorubicin—bone cancer	0.00332	0.00423	CcSEcCtD
Desonide—Hyperhidrosis—Doxorubicin—bone cancer	0.0033	0.00421	CcSEcCtD
Desonide—Pain—Epirubicin—bone cancer	0.00316	0.00403	CcSEcCtD
Desonide—Pain—Doxorubicin—bone cancer	0.00292	0.00373	CcSEcCtD
Desonide—Pruritus—Methotrexate—bone cancer	0.00279	0.00356	CcSEcCtD
Desonide—Pruritus—Epirubicin—bone cancer	0.00261	0.00333	CcSEcCtD
Desonide—Rash—Methotrexate—bone cancer	0.00249	0.00317	CcSEcCtD
Desonide—Dermatitis—Methotrexate—bone cancer	0.00249	0.00317	CcSEcCtD
Desonide—Headache—Methotrexate—bone cancer	0.00247	0.00315	CcSEcCtD
Desonide—Pruritus—Doxorubicin—bone cancer	0.00242	0.00308	CcSEcCtD
Desonide—Rash—Epirubicin—bone cancer	0.00233	0.00297	CcSEcCtD
Desonide—Dermatitis—Epirubicin—bone cancer	0.00233	0.00297	CcSEcCtD
Desonide—Headache—Epirubicin—bone cancer	0.00231	0.00295	CcSEcCtD
Desonide—Rash—Doxorubicin—bone cancer	0.00216	0.00275	CcSEcCtD
Desonide—Dermatitis—Doxorubicin—bone cancer	0.00215	0.00275	CcSEcCtD
Desonide—Headache—Doxorubicin—bone cancer	0.00214	0.00273	CcSEcCtD
